Home/Filings/4/0001562180-19-006221
4//SEC Filing

GARDNER JASON 4

Accession 0001562180-19-006221

CIK 0001690585other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 6:22 PM ET

Size

6.7 KB

Accession

0001562180-19-006221

Insider Transaction Report

Form 4
Period: 2019-12-20
GARDNER JASON
DirectorSee Remarks
Transactions
  • Sale

    Common Stock

    2019-12-20$15.16/sh76,711$1,162,617268,109 total
Holdings
  • Common Stock

    (indirect: By Trust)
    359,092
  • Common Stock

    (indirect: By Trust)
    292,990
Footnotes (2)
  • [F1]This trade is pursuant to an active 10b5-1 plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $15.10 to $15.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Magenta Therapeutics, Inc.

CIK 0001690585

Entity typeother

Related Parties

1
  • filerCIK 0001741286

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 6:22 PM ET
Size
6.7 KB